scispace - formally typeset
H

Hiroshi Ikegami

Researcher at Kindai University

Publications -  257
Citations -  10773

Hiroshi Ikegami is an academic researcher from Kindai University. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 48, co-authored 245 publications receiving 9812 citations. Previous affiliations of Hiroshi Ikegami include Osaka University & Aichi Gakuin University.

Papers
More filters
Journal ArticleDOI

Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms

TL;DR: The MIN6 cell line will be especially useful to analyze the molecular mechanisms by which beta cells regulate insulin secretion in response to extracellular glucose concentrations, and a possible role of GT isoforms in glucose sensing by beta cells is discussed.
Journal ArticleDOI

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

Anubha Mahajan, +395 more
- 01 Mar 2014 - 
TL;DR: In this paper, the authors aggregated published meta-analyses of genome-wide association studies (GWAS), including 26,488 cases and 83,964 controls of European, east Asian, south Asian and Mexican and Mexican American ancestry.
Journal ArticleDOI

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians

Yoon Shin Cho, +72 more
- 01 Jan 2012 - 
TL;DR: The combined analysis identified eight new T2D loci reaching genome-wide significance, which mapped in or near GLIS3, PEPD, FITM2-R3HDML-HNF4A, KCNK16, MAEA, GCC1-PAX4, PSMD6 and ZFAND3, which may regulate glucose-dependent insulin secretion in the pancreas.
Journal ArticleDOI

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives

TL;DR: Troglitazone treatment induces improvement in both glucose metabolism and blood pressure control in essential hypertensive patients with diabetes mellitus, suggesting that insulin resistance or plasma insulin level plays a role in the pathogenesis of essential hypertension.